Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1978 | 2399 | 36.5 | 74% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
237 | 3 | INFLUENZA//RESPIRATORY SYNCYTIAL VIRUS//AVIAN INFLUENZA | 47995 |
76 | 2 | INFLUENZA//AVIAN INFLUENZA//INFLUENZA VIRUS | 27762 |
1978 | 1 | NEURAMINIDASE INHIBITORS//OSELTAMIVIR//ZANAMIVIR | 2399 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | NEURAMINIDASE INHIBITORS | authKW | 2653386 | 12% | 75% | 277 |
2 | OSELTAMIVIR | authKW | 2497489 | 14% | 59% | 333 |
3 | ZANAMIVIR | authKW | 1462746 | 6% | 78% | 147 |
4 | PERAMIVIR | authKW | 676492 | 3% | 87% | 61 |
5 | NEURAMINIDASE | authKW | 513289 | 7% | 23% | 179 |
6 | OSELTAMIVIR RESISTANCE | authKW | 458144 | 2% | 86% | 42 |
7 | LANINAMIVIR | authKW | 433055 | 1% | 97% | 35 |
8 | INFLUENZA | authKW | 322399 | 17% | 6% | 413 |
9 | H275Y | authKW | 204330 | 1% | 94% | 17 |
10 | TAMIFLU | authKW | 202547 | 2% | 43% | 37 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Virology | 20087 | 22% | 0% | 533 |
2 | Infectious Diseases | 9068 | 19% | 0% | 450 |
3 | Pharmacology & Pharmacy | 7332 | 33% | 0% | 799 |
4 | Microbiology | 3920 | 18% | 0% | 429 |
5 | Chemistry, Medicinal | 2697 | 11% | 0% | 253 |
6 | Immunology | 508 | 9% | 0% | 210 |
7 | Medicine, General & Internal | 368 | 7% | 0% | 177 |
8 | Chemistry, Organic | 133 | 5% | 0% | 122 |
9 | Integrative & Complementary Medicine | 120 | 1% | 0% | 24 |
10 | Biochemical Research Methods | 83 | 3% | 0% | 71 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | VIRUS SURVEILLANCE DIAG BRANCH | 124489 | 1% | 65% | 15 |
2 | INFLUENZA | 55513 | 4% | 5% | 84 |
3 | ABORATING SURVEILLANCE EPIDEMIOL CONTRO | 53026 | 0% | 83% | 5 |
4 | ABORATING REFERENCE INFLUENZA | 41476 | 1% | 22% | 15 |
5 | INFLUENZA VIRUS | 39196 | 1% | 14% | 22 |
6 | CORP SAFETY HLTH ENVIRONM PROTECT | 38180 | 0% | 100% | 3 |
7 | I MECHNIKOV VACCINES SERA | 38180 | 0% | 100% | 3 |
8 | J AN PHYS ASSOC | 38180 | 0% | 100% | 3 |
9 | ANTIVIRAL | 34500 | 2% | 7% | 37 |
10 | INT HLTH PUBL HLTH | 31811 | 0% | 50% | 5 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ANTIVIRAL RESEARCH | 74002 | 6% | 4% | 142 |
2 | INFLUENZA AND OTHER RESPIRATORY VIRUSES | 34900 | 2% | 6% | 48 |
3 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 11787 | 6% | 1% | 149 |
4 | ANTIVIRAL THERAPY | 10275 | 2% | 2% | 39 |
5 | JOURNAL OF INFECTION AND CHEMOTHERAPY | 7563 | 1% | 2% | 26 |
6 | EUROSURVEILLANCE | 4050 | 1% | 1% | 23 |
7 | JOURNAL OF CLINICAL VIROLOGY | 3842 | 1% | 1% | 32 |
8 | JOURNAL OF INFECTIOUS DISEASES | 2860 | 3% | 0% | 64 |
9 | EXPERT REVIEW OF ANTI-INFECTIVE THERAPY | 2162 | 1% | 1% | 13 |
10 | EMERGING INFECTIOUS DISEASES | 1951 | 1% | 1% | 30 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | NEURAMINIDASE INHIBITORS | 2653386 | 12% | 75% | 277 | Search NEURAMINIDASE+INHIBITORS | Search NEURAMINIDASE+INHIBITORS |
2 | OSELTAMIVIR | 2497489 | 14% | 59% | 333 | Search OSELTAMIVIR | Search OSELTAMIVIR |
3 | ZANAMIVIR | 1462746 | 6% | 78% | 147 | Search ZANAMIVIR | Search ZANAMIVIR |
4 | PERAMIVIR | 676492 | 3% | 87% | 61 | Search PERAMIVIR | Search PERAMIVIR |
5 | NEURAMINIDASE | 513289 | 7% | 23% | 179 | Search NEURAMINIDASE | Search NEURAMINIDASE |
6 | OSELTAMIVIR RESISTANCE | 458144 | 2% | 86% | 42 | Search OSELTAMIVIR+RESISTANCE | Search OSELTAMIVIR+RESISTANCE |
7 | LANINAMIVIR | 433055 | 1% | 97% | 35 | Search LANINAMIVIR | Search LANINAMIVIR |
8 | INFLUENZA | 322399 | 17% | 6% | 413 | Search INFLUENZA | Search INFLUENZA |
9 | H275Y | 204330 | 1% | 94% | 17 | Search H275Y | Search H275Y |
10 | TAMIFLU | 202547 | 2% | 43% | 37 | Search TAMIFLU | Search TAMIFLU |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SAMSON, M , PIZZORNO, A , ABED, Y , BOIVIN, G , (2013) INFLUENZA VIRUS RESISTANCE TO NEURAMINIDASE INHIBITORS.ANTIVIRAL RESEARCH. VOL. 98. ISSUE 2. P. 174-185 | 111 | 99% | 101 |
2 | NGUYEN, HT , FRY, AM , GUBAREVA, LV , (2012) NEURAMINIDASE INHIBITOR RESISTANCE IN INFLUENZA VIRUSES AND LABORATORY TESTING METHODS.ANTIVIRAL THERAPY. VOL. 17. ISSUE 1. P. 159-173 | 91 | 91% | 66 |
3 | MCKIMM-BRESCHKIN, JL , (2013) INFLUENZA NEURAMINIDASE INHIBITORS: ANTIVIRAL ACTION AND MECHANISMS OF RESISTANCE.INFLUENZA AND OTHER RESPIRATORY VIRUSES. VOL. 7. ISSUE . P. 25-36 | 86 | 97% | 40 |
4 | LAPLANTE, J , ST GEORGE, K , (2014) ANTIVIRAL RESISTANCE IN INFLUENZA VIRUSES LABORATORY TESTING.CLINICS IN LABORATORY MEDICINE. VOL. 34. ISSUE 2. P. 387-+ | 96 | 93% | 1 |
5 | PIZZORNO, A , ABED, Y , BOIVIN, G , (2011) INFLUENZA DRUG RESISTANCE.SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE. VOL. 32. ISSUE 4. P. 409-422 | 97 | 82% | 30 |
6 | SCHIRMER, P , HOLODNIY, M , (2009) OSELTAMIVIR FOR TREATMENT AND PROPHYLAXIS OF INFLUENZA INFECTION.EXPERT OPINION ON DRUG SAFETY. VOL. 8. ISSUE 3. P. 357 -371 | 106 | 82% | 24 |
7 | LI, TCM , CHAN, MCW , LEE, N , (2015) CLINICAL IMPLICATIONS OF ANTIVIRAL RESISTANCE IN INFLUENZA.VIRUSES-BASEL. VOL. 7. ISSUE 9. P. 4929 -4944 | 73 | 82% | 18 |
8 | SPANAKIS, N , PITIRIGA, V , GENNIMATA, V , TSAKRIS, A , (2014) A REVIEW OF NEURAMINIDASE INHIBITOR SUSCEPTIBILITY IN INFLUENZA STRAINS.EXPERT REVIEW OF ANTI-INFECTIVE THERAPY. VOL. 12. ISSUE 11. P. 1325 -1336 | 78 | 88% | 16 |
9 | GRIENKE, U , SCHMIDTKE, M , VON GRAFENSTEIN, S , KIRCHMAIR, J , LIEDL, KR , ROLLINGER, JM , (2012) INFLUENZA NEURAMINIDASE: A DRUGGABLE TARGET FOR NATURAL PRODUCTS.NATURAL PRODUCT REPORTS. VOL. 29. ISSUE 1. P. 11 -36 | 101 | 62% | 56 |
10 | TSIODRAS, S , NIKOLOPOULOS, G , BONOVAS, S , (2012) ANTIVIRALS USED FOR INFLUENZA CHEMOPROPHYLAXIS.CURRENT MEDICINAL CHEMISTRY. VOL. 19. ISSUE 35. P. 5947 -5956 | 91 | 77% | 1 |
Classes with closest relation at Level 1 |